
Levi & Korsinsky, LLP has started an investigation into potential breaches of fiduciary duty by Select Medical Holdings Corporation's Board of Directors. The probe concerns the board's approval of a $16.50 per share acquisition deal by a consortium led by company executives and a private equity firm. The investigation aims to determine if the board acted in the best interests of shareholders. Investors who bought shares on or before March 2, 2026, are encouraged to learn more about their rights and the legal action.